Skip to main content
DBD
NYSE Technology

10% Owner Millstreet Capital Sells $41.6M in Diebold Nixdorf Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
7
Price
$84.98
Mkt Cap
$2.943B
52W Low
$53.1
52W High
$89.05
52W Position info
60% above low
Off High info
4.6% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

DBD sits 60% above its 52-week low of $53.1.

Summary

Millstreet Capital Management, a 10% owner, reported selling approximately $41.6 million worth of Diebold Nixdorf common shares in open market transactions between June 8 and June 25, 2026.


Key Events · Ownership and Investor Activity · DBD

  • Significant Share Sales

    Millstreet Capital Management, a 10% owner, sold 500,006 common shares for approximately $41.6 million through multiple open market transactions from June 8 to June 25, 2026.

  • Continued Stake Reduction

    Following these sales, Millstreet Capital Management's aggregate ownership stands at 4,204,432 shares, representing 12.14% of the outstanding common shares. This marks a continued reduction in their position.

  • Sales Near 52-Week High

    These sales occurred while Diebold Nixdorf's stock is trading near its 52-week high, potentially allowing the investor to lock in gains.


Analysis · DBD · Technology

This Schedule 13D/A filing details significant open market sales by Millstreet Capital Management, a major institutional investor. The sale of approximately $41.6 million worth of shares, representing over 1.4% of the company's market capitalization, indicates a continued reduction in their stake. While 10% owners often rebalance portfolios, the magnitude of these sales, especially following previous large sales, could be interpreted as a lack of conviction or a move to reduce exposure. The stock is currently trading near its 52-week high, which might be a factor in the timing of these sales.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DBD was trading at $84.98 on NYSE in the Technology sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $53.10 to $89.05. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DBD - Latest Insights

DBD
Oct 28, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $57.00
Real-time Price: $52.99 info
Change: -$4.01 (-7%) info
Market Cap: $1.772B info
DBD
Oct 28, 2026, 7:17 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $67.49
Real-time Price: $52.99 info
Change: -$14.50 (-21%) info
Market Cap: $1.772B info
DBD
Oct 28, 2026, 7:06 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $67.49
Real-time Price: $52.99 info
Change: -$14.50 (-21%) info
Market Cap: $1.772B info
DBD
Oct 05, 2026, 2:47 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $65.58
Real-time Price: $52.99 info
Change: -$12.59 (-19%) info
Market Cap: $1.772B info
DBD
Jul 31, 2026, 4:27 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $73.93
Real-time Price: $52.99 info
Change: -$20.94 (-28%) info
Market Cap: $1.772B info